Global Live Cell Encapsulation Market Report and Forecast 2024-2032
Market Report I 2023-10-01 I 140 Pages I EMR Inc.
Global Live Cell Encapsulation Market Report and Forecast 2024-2032
Global Live Cell Encapsulation Market Outlook
The global live cell encapsulation market size was valued at USD 258.2 million in 2023, driven by a confluence of technological, clinical, and commercial trends across the globe. The market size is anticipated to grow at a CAGR of 3.6% during the forecast period of 2024-2032 to achieve a value of USD 356.5 million by 2032.
Live Cell Encapsulation: Introduction
Live cell encapsulation is a cutting-edge technique that involves enclosing living cells within a biocompatible, semi-permeable barrier. This barrier effectively shields the encapsulated cells from direct external factors yet permit the exchange of essential nutrients and metabolic waste products. By providing a controlled environment, encapsulation improves cell viability, longevity, and functionality. This technology has garnered attention in biomedicine and biotechnology for its potential applications in tissue engineering, drug delivery, and to transplant cells without the typical concerns of immune rejection.
Key Trends in the Global Live Cell Encapsulation Market
The global live cell encapsulation market was witnessing a transformative phase driven by a confluence of technological, clinical, and commercial trends. A pronounced shift towards regenerative medicine was invigorating the demand for encapsulation technologies, offering unprecedented solutions in drug delivery and cellular therapies. With technological breakthroughs paving the way, advanced biocompatible materials have emerged as game-changers, broadening the horizons of encapsulation applications.
Furthermore, the landscape was brimming with collaborative ventures, as research institutions joined forces with industry behemoths to expedite encapsulation innovations. This synergy was further buoyed by a surge in investments, underscoring the market's robust growth potential. However, intertwined with this optimism were challenges, predominantly regulatory intricacies, and cost implications. Additionally, the geographic epicentre of activities was gradually expanding, with emerging markets showcasing a burgeoning interest in this domain, driven by enhanced healthcare infrastructure and intensified R&D endeavours.
Global Live Cell Encapsulation Market Segmentation
Market Breakup by Manufacturing Techniques
- Simple Dripping
- Electrostatic Dripping
- Coaxial Airflow
- Liquid-Jet Break-Up
- Vibrating-Jet Technique
- Jet Cutting
- Rotating Disk Atomization
Market Breakup by Polymer Type
- Alginate
- HEMA-MMA (HydroxyethylMethacrylate-Methyl Methacrylate)
- Chitosan
- Siliceous Encapsulates
- Cellulose Sulphate
- PAN-PVC (Poly Acrylonitrile Vinyl Chloride)
- Others
Market Breakup by Application
- Drug Delivery
- Regenerative Medicine
- Cell Transplantation
- Probiotics
- Research
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Live Cell Encapsulation Market Overview
The global live cell encapsulation market represents a dynamic sector at the nexus of biotechnology and medicine. Rooted in the principle of enclosing living cells within a semi-permeable, biocompatible membrane, this technology promises enhanced cell survival, controlled therapeutic delivery, and reduced immune reactions. The market's momentum is primarily fuelled by the burgeoning demand in regenerative medicine and the potential for novel treatment modalities for chronic diseases. With advancements in material science, innovative biocompatible matrices are continually being developed, broadening encapsulation applications. The market is further invigorated by robust investments, both from venture capitals and pharmaceutical giants, eager to harness the potential of cell encapsulation.
Collaborative efforts between academia and industry are also on the rise, seeking to streamline research and commercialization. Yet, the journey isn't without challenges, with regulatory hurdles and cost considerations posing significant barriers. Nonetheless, with its transformative potential, the global live cell encapsulation market is poised for substantial growth, with a keen eye on innovations and patient-centric solutions.
Global Live Cell Encapsulation Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- ViaCyte, Inc.
- Living Cell Technologies Limited
- Balchem Inc.
- Lycored
- BUCHI Labortechnik AG
- Sigilon Therapeutics, Inc.
- Encapsys, LLC.
- Evonik Industries AG
- MIKROCAPS
- Neurotech Pharmaceuticals
- BioTime, Inc
- Gloriana Therapeutics
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Live Cell Encapsulation Market Overview
3.1 Global Live Cell Encapsulation Market Historical Value (2017-2023)
3.2 Global Live Cell Encapsulation Market Forecast Value (2024-2032)
4 Global Live Cell Encapsulation Market Landscape
4.1 Global Live Cell Encapsulation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Live Cell Encapsulation Product Landscape
4.2.1 Analysis by Manufacturing Techniques
4.2.2 Analysis by Polymer Type
4.2.3 Analysis by Application
5 Global Live Cell Encapsulation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter's Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Live Cell Encapsulation Market Segmentation
6.1 Global Live Cell Encapsulation Market by Manufacturing Techniques
6.1.1 Market Overview
6.1.2 Simple Dripping
6.1.3 Electrostatic Dripping
6.1.4 Coaxial Airflow
6.1.5 Liquid-Jet Break-Up
6.1.6 Vibrating-Jet Technique
6.1.7 Jet Cutting
6.1.8 Rotating Disk Atomization
6.2 Global Live Cell Encapsulation Market by Polymer Type
6.2.1 Market Overview
6.2.2 Alginate
6.2.3 HEMA-MMA (HydroxyethylMethacrylate-Methyl Methacrylate)
6.2.4 Chitosan
6.2.5 Siliceous Encapsulates
6.2.6 Cellulose Sulphate
6.2.7 PAN-PVC (Poly Acrylonitrile Vinyl Chloride)
6.2.8 Others
6.3 Global Live Cell Encapsulation Market by Application
6.3.1 Market Overview
6.3.2 Drug Delivery
6.3.3 Regenerative Medicine
6.3.4 Cell Transplantation
6.3.5 Probiotics
6.3.6 Research
6.4 Global Live Cell Encapsulation Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Live Cell Encapsulation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Live Cell Encapsulation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Live Cell Encapsulation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Live Cell Encapsulation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Live Cell Encapsulation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Merck KGaA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 ViaCyte, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Living Cell Technologies Limited
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Balchem Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Lycored
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 BUCHI Labortechnik AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Sigilon Therapeutics, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Encapsys, LLC.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Evonik Industries AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 MIKROCAPS
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Neurotech Pharmaceuticals
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 BioTime, Inc
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Gloriana Therapeutics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Live Cell Encapsulation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.